Search for: "A----. B v. C----. D" Results 2561 - 2580 of 10,360
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Nov 2018, 11:06 pm by Roel van Woudenberg
Main Request, Rule 111(2) EPC2.1 At the time when the contested decision was issued, the requirements for issuing a refusal using a standard form referring to previous communications were set out in the Guidelines for Examination in the EPO, November 2016, C-V, 15.2.According to the first paragraph of Guideline C-V, 15.2, in order to comply with the requirement that a decision be reasoned (Rule 111(2)), it is only possible to use this form of decision where the… [read post]
3 Mar 2015, 11:19 am by Arthur F. Coon
Opn. at p. 11, comparing Guideline §§ 15300.2(c) and 15061(b)(3)); accordingly, “under appellants’ view, the categorical exemptions would serve no purpose; they would apply only when the proposed project is by statute and Guidelines [§]15061[](b)(3), already outside of CEQA review. [read post]
3 Nov 2006, 12:26 pm
  In particular, I am wondering how the grants in Claiborne and Rita will impact (a) the reasonableness en banc in progress in the Sixth and Ninth Circuits, (b) the development of reasonableness doctrines in other circuits, (c) the work of the US Sentencing Commission, and (d) the adovacy of DOJ for a Booker fix. [read post]
12 Mar 2017, 11:14 pm by Steve Baird
There are some letters of the alphabet, such as B, C, D, E, P, T, etc., which are recognized as sounding alike. [read post]
15 Aug 2007, 10:01 pm
  Neither company would appear to be a direct infringer of a patent claim reciting steps A, B, C, and D. [read post]
10 Aug 2010, 3:01 pm by Oliver G. Randl
Be that as it may, it also contains an interesting passage where the various features of a somewhat unorthodox claim are analysed in view of a novelty assessment:[33] Claim 1 of auxiliary request 11 refers to a liquid composition which (a) comprises an interferon-beta, (b) comprises an amino acid stabilizing agent selected from the group consisting of 0.5% to 5% (w/v) arginine-HC1, 0.50% to 2.0% (w/v) glycine, and 1.47% to 2.94% (w/v) glutamic acid, (c)… [read post]
12 Aug 2016, 10:30 am by Rebecca Tushnet
A lot of the problem w/abusive litigation is C&D letters, choosing to sue in improper venue; Ds may capitulate before it’s litigated. [read post]